E-mail An Article To Your Friend |
|
You have chosen to share the following article with your friend:
Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor Of CK2 Simply fill in your name and email address, and the name and email address of the friend you wish to send the article to. If you wish to add any additional comments of your own, these can be done in the Extra Text box provided. |
The details you provide will not be stored by us, will not be used to send unsolicited e-mail, and will not be sold to a 3rd party. Privacy Policy
